The board of Transcenta Holding Limited - B (ASX: 06628) has announced a series of proposed changes to its composition and committee memberships.

It is recommended that Dr. Hansen Xu be appointed as a Non-Executive Director and that Dr. Jun Bao be appointed as an Independent Non-Executive Director. These appointments are subject to approval by the company's shareholders at the Annual General Meeting scheduled for June 30, 2026.

Concurrently, Dr. Kumar Srinivasan and Mr. Zhihua Zhang have tendered their resignations as Independent Non-Executive Directors to dedicate more time to other commitments. Their resignations will become effective upon the appointments of Dr. Xu and Dr. Bao.

Following their respective departures, Dr. Srinivasan will step down from his roles as Chairman of the Remuneration Committee and as a member of the Nomination Committee. Mr. Zhang will relinquish his positions as Chairman of the Nomination Committee, and as a member of both the Audit Committee and the Remuneration Committee.

Changes to the composition of the Audit, Remuneration, and Nomination Committees will also take effect once the new directors are appointed. Under the proposed changes, Dr. Jun Bao will join the Remuneration, Audit, and Nomination Committees. Ms. Wei Chen will be appointed as the Chairman of the Remuneration Committee. Dr. Hansen Xu will become a member of the Remuneration Committee, and Dr. Xueming Qian will be appointed as the Chairman of the Nomination Committee.